Published-Ahead-of-Print April 4, 2007, DOI:10.2164/jandrol.107.002675
Journal of Andrology, Vol. 28, No. 5, September/October 2007
Copyright © American Society of Andrology
DOI: 10.2164/jandrol.107.002675
Isolation and Characterization of LNCaP Sublines Differing in Hormone Sensitivity
KAZUHIRO IGUCHI*,
,
KENICHIRO ISHII
,
,
TORU NAKANO*,
TAKASHI OTSUKA*,
SHIGEYUKI USUI*,
YOSHIKI SUGIMURA
AND
KAZUYUKI HIRANO*
From the * Laboratory of Pharmaceutics, Gifu
Pharmaceutical University, Gifu, Japan; and
Department of Nephro-Urologic Surgery and
Andrology, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
|
Correspondence to: Dr Kazuyuki Hirano, Laboratory of Pharmaceutics, Gifu
Pharmaceutical University, 5-6-1 Mitahora-higashi, Gifu 502-8585, Japan
(e-mail:
hirano{at}gifu-pu.ac.jp).. |
Prostate cancer is a heterogeneous disease with varying degrees of androgen
sensitivity. In this study, we performed a limiting dilution of human prostate
LNCaP cells, and isolated two sublines, LNCaP-E9 and LNCaP-G4, with
differential hormone-sensitivity. Two LNCaP sublines were obtained by the
limiting dilution method. The growth of E9 cells was decreased in the presence
of androgens, while that of androgen-treated G4 cells was biphasic. Although
the androgen receptor expression level in E9 cells was similar to that seen in
G4 cells, the expression of PSA mRNA and protein was significantly lower in
the E9 cells. Moreover, the androgen-based stimulation of PSA mRNA expression
was less sensitive in E9 cells than G4 cells. Intracellular zinc level did not
differ between E9 and G4 cells, but ZnT3 mRNA expression was significantly
higher in the E9 cells. When the cells were grafted at the subrenal capsule,
the number of CD31-positive vessels with a lumen was approximately 2.5 times
higher than that in G4 tumors. LNCaP-E9 cells show lower androgen sensitivity
than LNCaP-G4 cells. E9 and G4 cells would be helpful for understanding the
biology of hormone-refractory prostate cancer.
Key words: Androgen sensitivity, PSA, limiting dilution
This article has been cited by other articles:

|
 |

|
 |
 
N. Dubi, L. Gheber, D. Fishman, I. Sekler, and M. Hershfinkel
Extracellular zinc and zinc-citrate, acting through a putative zinc-sensing receptor, regulate growth and survival of prostate cancer cells
Carcinogenesis,
September 1, 2008;
29(9):
1692 - 1700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Iguchi, M. Ito, S. Usui, A. Mizokami, M. Namiki, and K. Hirano
Downregulation of Thymosin {beta}4 Expression by Androgen in Prostate Cancer LNCaP Cells
J Androl,
March 1, 2008;
29(2):
207 - 212.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by The American Society of Andrology.